Russell Investments Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-743
Closed -$1.03K 3809
2024
Q4
$1.03K Buy
+743
New +$1.03K ﹤0.01% 3521
2024
Q3
Sell
-72,955
Closed -$126K 3707
2024
Q2
$126K Buy
+72,955
New +$126K ﹤0.01% 2578
2024
Q1
Sell
-73,102
Closed -$243K 3315
2023
Q4
$243K Buy
+73,102
New +$243K ﹤0.01% 2393
2023
Q3
Sell
-1,155
Closed -$4.93K 3540
2023
Q2
$4.93K Sell
1,155
-86,695
-99% -$370K ﹤0.01% 3112
2023
Q1
$601K Sell
87,850
-2,644
-3% -$18.1K ﹤0.01% 2188
2022
Q4
$717K Buy
90,494
+8,141
+10% +$64.5K ﹤0.01% 2138
2022
Q3
$789K Sell
82,353
-25,689
-24% -$246K ﹤0.01% 2038
2022
Q2
$781K Buy
108,042
+86,542
+403% +$626K ﹤0.01% 2068
2022
Q1
$277K Buy
+21,500
New +$277K ﹤0.01% 2390
2021
Q2
Sell
-66,535
Closed -$971K 3217
2021
Q1
$971K Sell
66,535
-24,316
-27% -$355K ﹤0.01% 2256
2020
Q4
$1.58M Buy
90,851
+25,169
+38% +$437K ﹤0.01% 1881
2020
Q3
$1.2M Buy
65,682
+14,393
+28% +$264K ﹤0.01% 1978
2020
Q2
$915K Sell
51,289
-10,467
-17% -$187K ﹤0.01% 2107
2020
Q1
$1M Buy
61,756
+24,956
+68% +$405K ﹤0.01% 1839
2019
Q4
$662K Sell
36,800
-63,204
-63% -$1.14M ﹤0.01% 2296
2019
Q3
$2.03M Buy
+100,004
New +$2.03M ﹤0.01% 1679
2017
Q3
Sell
-5,888
Closed -$84K 2950
2017
Q2
$84K Sell
5,888
-19,839
-77% -$283K ﹤0.01% 2828
2017
Q1
$545K Sell
25,727
-11,390
-31% -$241K ﹤0.01% 2391
2016
Q4
$1.05M Buy
+37,117
New +$1.05M ﹤0.01% 2150